Arcis Biotechnology and Opentrons Sign Distribution Agreement

Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a commercial distribution agreement with Opentrons, the developer of affordable pipetting robots. The agreement allows Opentrons to directly distribute Arcis’ sample preparation kits to laboratories … Continued

Avvio marks further UK growth

Global technology provider Avvio has upsized its London offices and is making a number of new appointments as it continues its impressive global growth. Located in the heart of the capital – nestled between Charing Cross and Leicester Square – … Continued

Spotlight On: Axol Bioscience

As part of our ‘Spotlight On’ series, we focus on Axol Bioscience, a company who provides human cell culture systems for medical research, disease modelling and drug development. Axol Bioscience supplies high quality human cells, both healthy and diseased, to … Continued

Scancell raises £3.9m from Vulpes Life Sciences

Scancell, the developer of novel immunotherapies for the treatment of cancer, today announces that it has raised £3.9m at a price of 5 pence per share from Vulpes Life Sciences Fund (“Vulpes”) under existing shareholder authorities. Vulpes Investment Management was … Continued

Money Dashboard integrates with three new providers

Money management app Money Dashboard has released integrations with three new account providers – Revolut, Chip and Marcus by Goldman Sachs. The integrations help consumers track spending and progress towards their savings goals in real time. Money Dashboard is the first … Continued

Synpromics announces partnership with Lonza Pharma & Biotech

Lonza chooses Synpromics’ novel inducible promoter platform to  manufacture  biopharmaceuticals Edinburgh, UK, 16th May 2019 / Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manufacturing of biopharmaceuticals. The … Continued

Arecor: New Global Partner Signed & Clinical Trial Update

Cambridge, UK., 3rd May 2019: Arecor, today announces that it has signed a collaboration with a new major global pharmaceutical partner. Under the collaboration, Arecor will leverage its ArestatTM technology to develop superior liquid formulations of its partner’s proprietary products. The partner will … Continued